Qi-Jin Shu (Qijin Shu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Transforming Growth Factor

Clostridium Difficile

Metastatic Breast Cancer

Top Venues

Integrative cancer therapies

Evidence-based complementary and alternative medicine : eCAM

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Shuyi Chen, Rui Yu, Fangmin Zhao, Lin Sun, Yudan Yin, Gaochenxi Zhang, Qunwei Chen, Qi-Jin Shu
Network pharmacology and molecular docking to explore the mechanism of a clinical proved recipe for external use of clearing heat and removing dampness in the treatment of immune-related cutaneous adverse events. Medicine 103 (11) (2024)
Shu-Yi Chen, Fang-Min Zhao, Rui Yu, Lin Sun, Yu-Dan Yin, Gao-Chen-Xi Zhang, Jia-Yao Yang, Qi-Jin Shu
Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study. Integrative cancer therapies 23 (2024)
Shu-Yi Chen, Fang-Min Zhao, Rui Yu, Lin Sun, Yu-Dan Yin, Gao-Chen-Xi Zhang, Jia-Yao Yang, Qi-Jin Shu
Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study. Integrative cancer therapies 23 (2024)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Liumei Shou, Tianyu Shao, Jialu Chen, Yao Zhang, Qi-Jin Shu
The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial. Integrative cancer therapies 22 (2023)
Tianyu Shao, Yao Zhang, Jiaping Liu, Jialu Chen, Qi-Jin Shu, Liumei Shou
Capecitabine-induced enterocolitis: a case report and pharmacogenetic profile. Pharmacogenomics 23 (18) (2022)
Shuying Dai, Gaochenxi Zhang, Fangmin Zhao, Qi-Jin Shu
Study on the Molecular Mechanism of the Herbal Couple Sparganii Rhizoma-Curcumae Rhizoma in the Treatment of Lung Cancer Based on Network Pharmacology. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Qunwei Chen, Wan-Fu Lin, Zifei Yin, Yong Zou, Shufang Liang, Shanming Ruan, Peifeng Chen, Shu Li, Qi-Jin Shu, Bin-Bin Cheng, Chang-Quan Ling
Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)